The immunosuppressive properties of TME are dominated by TAMs-M2-type TAMs inhibit the cytotoxicity of CD8+ T cells through the secretion of IL-10 and TGF-β, while enhancing the anti-apoptotic capacity of tumour cells, leading to a reduction in the killing efficiency of chemotherapeutic agents. The gene discussed is TGFB1; the disease is neoplasm.